| [1] |
XU K, YOU H, SU HY, et al. Clinical study and reclassification of the vascular lesion in patients with Budd-Chiari syndrome[J]. Chin J Radiol, 2003, 37(10): 896-900. DOI: 10.3760/j.issn:1005-1201.2003.10.008. |
| [2] |
LI Y, DE STEFANO V, LI H, et al. Epidemiology of Budd-Chiari syndrome: A systematic review and meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2019, 43(4): 468-474. DOI: 10.1016/j.clinre.2018.10.014. |
| [3] |
KI M, CHOI HY, KIM KA, et al. Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study[J]. Liver Int, 2016, 36(7): 1067-1073. DOI: 10.1111/liv.13008. |
| [4] |
GOEL A, MADHU K, ZACHARIAH U, et al. A study of aetiology of portal hypertension in adults (including the elderly) at a tertiary centre in southern India[J]. Indian J Med Res, 2013, 137(5): 922-927.
|
| [5] |
DARWISH MURAD S, PLESSIER A, HERNANDEZ-GUERRA M, et al. Etiology, management, and outcome of the Budd-Chiari syndrome[J]. Ann Intern Med, 2009, 151(3): 167-175. DOI: 10.7326/0003-4819-151-3-200908040-00004. |
| [6] |
MANCUSO A. Budd-Chiari syndrome in the West and the East: Same syndrome, different diseases[J]. Liver Int, 2019, 39(12): 2417. DOI: 10.1111/liv.14131. |
| [7] |
SHARMA A, KESHAVA SN, EAPEN A, et al. An update on the management of Budd-Chiari syndrome[J]. Dig Dis Sci, 2021, 66(6): 1780-1790. DOI: 10.1007/s10620-020-06485-y. |
| [8] |
ZHANG XM, LI YK, SHEN CY, et al. Preliminary study on etiology of Budd-Chiari syndrome through clinic and experiment[J]. Chin J Surg, 2010, (8): 569-572. DOI: 10.3760/cma.j.issn.0529-5815.2010.08.004. |
| [9] |
INCHINGOLO R, POSA A, MARIAPPAN M, et al. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review[J]. World J Gastroenterol, 2020, 26(34): 5060-5073. DOI: 10.3748/wjg.v26.i34.5060. |
| [10] |
FERRAL H, BEHRENS G, LOPERA J. Budd-Chiari syndrome[J]. AJR Am J Roentgenol, 2012, 199(4): 737-745. DOI: 10.2214/AJR.12.9098. |
| [11] |
VALLA DC. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West[J]. J Gastroenterol Hepatol, 2004, 19(s7): S204-S211. DOI: 10.1111/j.1440-1746.2004.03642.x. |
| [12] |
DARWISH MURAD S, VALLA DC, DE GROEN PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome[J]. Hepatology, 2004, 39(2): 500-508. DOI: 10.1002/hep.20064. |
| [13] |
DAS CJ, SONEJA M, TAYAL S, et al. Role of radiological imaging and interventions in management of Budd-Chiari syndrome[J]. Clin Radiol, 2018, 73(7): 610-624. DOI: 10.1016/j.crad.2018.02.003. |
| [14] |
Interventional Group, Radiology Society, Chinese Medical Association. Guidelines of the interventional treatment for Budd-Chiari syndrome[J]. Chin J Radiol, 2010, 44(4): 345-349. DOI: 10.3760/cma.j.issn.1005-1201.2010.04.003. |
| [15] |
KHATRI G, MERRICK L, MILLER FH. MR imaging of hepatocellular carcinoma[J]. Magn Reson Imaging Clin N Am, 2010, 18(3): 421-450, x. DOI: 10.1016/j.mric.2010.08.002. |
| [16] |
MA MT. Clinical application of ultrasonography in the diagnosis and differential diagnosis of Budd Chiari syndrome[D]. Taiyuan: Shanxi Medical University, 2012. DOI: 10.7666/d.y2127297. |
| [17] |
SHUKLA A, SHRESHTHA A, MUKUND A, et al. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)[J]. Hepatol Int, 2021, 15(3): 531-567. DOI: 10.1007/s12072-021-10189-4. |
| [18] |
|
DownLoad: